The Claim
In transfusion-dependent thalassemia (TDT) patients, there is a moderate positive correlation between fasting blood sugar (FBS) and HbA1c (r = 0.470, p = 0.004), indicating that despite overall elevated HbA1c levels, HbA1c still reflects some degree of glycemic variation in this population.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In people with a blood disorder called thalassemia who need regular blood transfusions, their long-term blood sugar marker (HbA1c) goes up when their daily fasting sugar goes up — so even though their HbA1c is usually high, it still gives some clue about their blood sugar changes.
See the scientific wording
A moderate positive correlation exists between fasting blood sugar (FBS) and HbA1c in transfusion-dependent thalassemia (TDT) patients (r = 0.470, p = 0.004), suggesting that while HbA1c is elevated overall, it still reflects some degree of glycemic variation within this population.
What the research says
1 studyThe study found that even though HbA1c levels are usually high in thalassemia patients, they still go up and down a bit with blood sugar levels, which supports the claim.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.